D-Peptide-Based Probe for CXCR4-Targeted Molecular Imaging and Radionuclide Therapy

The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research

(2020) Nathalie Percie du Sert et al.   BRITISH JOURNAL OF PHARMACOLOGY

Copper-64 PET imaging of the CXCR4 chemokine receptor using a cross-bridged cyclam bis-tetraazamacrocyclic antagonist

(2019) Ben Burke et al.   JOURNAL OF NUCLEAR MEDICINE

C-terminal–modified LY2510924: a versatile scaffold for targeting C-X-C chemokine receptor type 4

(2019) Kentaro Suzuki et al.   Scientific Reports

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

(2018) Geert Schoofs et al.   Jove-Journal of Visualized Experiments

CXCR4-directed theranostics in oncology and inflammation

(2018) Malte Kircher et al.   ANNALS OF NUCLEAR MEDICINE

Structural Analysis of Chemokine Receptor–Ligand Interactions

(2017) Marta Arimont et al.   JOURNAL OF MEDICINAL CHEMISTRY

Biodistribution, Pharmacokinetics, and Dosimetry of 177 Lu-, 90 Y-, and 111 In-Labeled Somatostatin Receptor Antagonist OPS201 in Comparison to the Agonist 177 Lu-DOTATATE: The Mass Effect

(2017) Guillaume P. Nicolas et al.   JOURNAL OF NUCLEAR MEDICINE

CXCR4 Ligands: The Next Big Hit?

(2017) Annemiek M.E. Walenkamp et al.   JOURNAL OF NUCLEAR MEDICINE

Al18F-Labeling Of Heat-Sensitive Biomolecules for Positron Emission Tomography Imaging

(2017) Frederik Cleeren et al.   Theranostics

[177Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic Agent

(2017) Margret Schottelius et al.   Theranostics

First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease

(2015) K. Herrmann et al.   JOURNAL OF NUCLEAR MEDICINE

Retention of [18F]fluoride on reversed phase HPLC columns

(2015) Dieter Ory et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Disclosing the CXCR4 Expression in Lymphoproliferative Diseases by Targeted Molecular Imaging

(2015) Hans Jürgen Wester et al.   Theranostics

A Novel CXCR4-Selective High-Affinity Fluorescent Probe and Its Application in Competitive Binding Assays

(2014) Yilei Yang et al.   BIOCHEMISTRY

CXC chemokine ligand 12 (CXCL12) and its receptor CXCR4

(2014) Takashi Nagasawa   JOURNAL OF MOLECULAR MEDICINE-JMM

A synthetic bivalent ligand of CXCR4 inhibits HIV infection

(2013) Yan Xu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Radiofluorination using aluminum-fluoride (Al18F)

(2013) William J McBride et al.   EJNMMI Research

Increased initiation and growth of tumor cell lines, cancer stem cells and biopsy material in mice using basement membrane matrix protein (Cultrex or Matrigel) co-injection

(2012) Rafael Fridman et al.   Nature Protocols

Stromal-Derived Factor-1 and Its Receptor, CXCR4, Are Constitutively Expressed by Mouse Liver Sinusoidal Endothelial Cells: Implications for the Regulation of Hematopoietic Cell Migration to the Liver During Extramedullary Hematopoiesis

(2011) Mayela Mendt et al.   STEM CELLS AND DEVELOPMENT